Published in J Control Release on December 19, 2005
Involvement of TRPC channels in lung cancer cell differentiation and the correlation analysis in human non-small cell lung cancer. PLoS One (2013) 0.87
Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug. AAPS PharmSciTech (2011) 0.87
Activation of Akt pathway by transcription-independent mechanisms of retinoic acid promotes survival and invasion in lung cancer cells. Mol Cancer (2013) 0.84
TIG3: an important regulator of keratinocyte proliferation and survival. J Invest Dermatol (2014) 0.82
Uptake of all-trans retinoic acid-containing aerosol by inhalation to lungs in a guinea pig model system--a pilot study. Exp Lung Res (2010) 0.78
Formation of ion pairing as an alternative to improve encapsulation and anticancer activity of all-trans retinoic acid loaded in solid lipid nanoparticles. Int J Nanomedicine (2012) 0.77
Luminescent proteins for high-speed single-cell and whole-body imaging. Nat Commun (2012) 2.24
Rapid degradation of Cdt1 upon UV-induced DNA damage is mediated by SCFSkp2 complex. J Biol Chem (2004) 1.46
piggyBac transposon-mediated long-term gene expression in mice. Mol Ther (2010) 1.33
Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting. J Control Release (2006) 1.15
Levels and concentration ratios of polychlorinated biphenyls and polybrominated diphenyl ethers in serum and breast milk in Japanese mothers. Environ Health Perspect (2006) 1.14
Strategies for in vivo delivery of siRNAs: recent progress. BioDrugs (2010) 1.14
Nonviral approaches for targeted delivery of plasmid DNA and oligonucleotide. J Pharm Sci (2008) 1.13
Targeted delivery systems of small interfering RNA by systemic administration. Drug Metab Pharmacokinet (2007) 1.10
Dysfunctional gastric emptying with down-regulation of muscle-specific microRNAs in Helicobacter pylori-infected mice. Gastroenterology (2010) 1.10
First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up. Gynecol Oncol (2003) 1.08
Small interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in mice. Biomaterials (2006) 1.07
Catalase delivery for inhibiting ROS-mediated tissue injury and tumor metastasis. Adv Drug Deliv Rev (2009) 1.07
Evaluation of proinflammatory cytokine production induced by linear and branched polyethylenimine/plasmid DNA complexes in mice. J Pharmacol Exp Ther (2006) 1.03
Molecular weight-dependent gene transfection activity of unmodified and galactosylated polyethyleneimine on hepatoma cells and mouse liver. Mol Ther (2003) 1.01
PEGylated lysine dendrimers for tumor-selective targeting after intravenous injection in tumor-bearing mice. J Control Release (2006) 0.99
Creation of pure nanodrugs and their anticancer properties. Angew Chem Int Ed Engl (2012) 0.99
Nonviral approaches satisfying various requirements for effective in vivo gene therapy. Biol Pharm Bull (2002) 0.96
PEGylated catalase prevents metastatic tumor growth aggravated by tumor removal. Free Radic Biol Med (2006) 0.96
Renal press-mediated transfection method for plasmid DNA and siRNA to the kidney. Biochem Biophys Res Commun (2008) 0.96
Plasmid DNA activates murine macrophages to induce inflammatory cytokines in a CpG motif-independent manner by complex formation with cationic liposomes. Biochem Biophys Res Commun (2002) 0.96
Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats. J Control Release (2007) 0.95
Inhibition of experimental hepatic metastasis by targeted delivery of catalase in mice. Clin Exp Metastasis (2004) 0.95
Inchinkoto, a herbal medicine, and its ingredients dually exert Mrp2/MRP2-mediated choleresis and Nrf2-mediated antioxidative action in rat livers. Am J Physiol Gastrointest Liver Physiol (2006) 0.94
Inhibition of tumour metastasis by targeted delivery of antioxidant enzymes. Expert Opin Drug Deliv (2006) 0.93
Pharmacokinetic considerations for targeted drug delivery. Adv Drug Deliv Rev (2012) 0.93
Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated O/W emulsions by macrophages. J Control Release (2006) 0.93
Lipid carrier systems for targeted drug and gene delivery. Chem Pharm Bull (Tokyo) (2005) 0.92
Development of polyethylene glycol-conjugated poly-S-nitrosated serum albumin, a novel S-Nitrosothiol for prolonged delivery of nitric oxide in the blood circulation in vivo. J Pharmacol Exp Ther (2005) 0.92
Induced-fit motion of a lid loop involved in catalysis in alginate lyase A1-III. Acta Crystallogr D Biol Crystallogr (2012) 0.92
Fetuin mediates hepatic uptake of negatively charged nanoparticles via scavenger receptor. Int J Pharm (2006) 0.91
Prevention of pulmonary metastasis from subcutaneous tumors by binary system-based sustained delivery of catalase. J Control Release (2009) 0.91
Prevention of hepatic ischemia/reperfusion injury by prolonged delivery of nitric oxide to the circulating blood in mice. Transplantation (2008) 0.91
Efficient gene transfection by histidine-modified chitosan through enhancement of endosomal escape. Bioconjug Chem (2010) 0.91
Gamma-polyglutamic acid-coated vectors for effective and safe gene therapy. J Control Release (2009) 0.91
Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells. J Control Release (2006) 0.90
Inhibition of experimental pulmonary metastasis by controlling biodistribution of catalase in mice. Int J Cancer (2002) 0.89
Aggressive sporadic histiocytic sarcoma with immunoglobulin heavy chain gene rearrangement and t(14;18). Int J Hematol (2010) 0.89
Enhanced anti-inflammation of inhaled dexamethasone palmitate using mannosylated liposomes in an endotoxin-induced lung inflammation model. Mol Pharmacol (2008) 0.88
Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes. J Pharm Sci (2005) 0.88
Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-beta gene and poly I: poly C in a murine lung metastasis model. Cancer Gene Ther (2003) 0.88
Factors affecting drug and gene delivery: effects of interaction with blood components. Crit Rev Ther Drug Carrier Syst (2002) 0.88
Intravenous fate of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes. Eur J Pharm Sci (2003) 0.88
Enhanced transfection efficiency into macrophages and dendritic cells by a combination method using mannosylated lipoplexes and bubble liposomes with ultrasound exposure. Hum Gene Ther (2010) 0.88
Mechanistic and empirical modeling of skin permeation of drugs. Adv Drug Deliv Rev (2003) 0.88
Biodistribution characteristics of amino acid dendrimers and their PEGylated derivatives after intravenous administration. J Control Release (2006) 0.88
SOD derivatives prevent metastatic tumor growth aggravated by tumor removal. Clin Exp Metastasis (2008) 0.87
Development of an ultrasound-responsive and mannose-modified gene carrier for DNA vaccine therapy. Biomaterials (2010) 0.87
Prevention of ischemia/reperfusion injury by hepatic targeting of nitric oxide in mice. J Control Release (2009) 0.87
Simultaneous delivery of doxorubicin and immunostimulatory CpG motif to tumors using a plasmid DNA/doxorubicin complex in mice. J Control Release (2009) 0.87
Contribution of hydrolase and phosphatase domains in soluble epoxide hydrolase to vascular endothelial growth factor expression and cell growth. Biol Pharm Bull (2009) 0.87
Inhibition of metastatic tumor growth by targeted delivery of antioxidant enzymes. J Control Release (2005) 0.87
Encapsulation of the synthetic retinoids Am80 and LE540 into polymeric micelles and the retinoids' release control. J Control Release (2009) 0.87
Examining the Sociocultural Context of HIV-related Risk Behaviors Among Kathoey (Male-to-female Transgender Women) Sex Workers in Bangkok, Thailand. J Assoc Nurses AIDS Care (2015) 0.87
Pharmacokinetic analysis of in vivo disposition of succinylated proteins targeted to liver nonparenchymal cells via scavenger receptors: importance of molecular size and negative charge density for in vivo recognition by receptors. J Pharmacol Exp Ther (2002) 0.87
Targeting efficiency of galactosylated liposomes to hepatocytes in vivo: effect of lipid composition. Pharm Res (2002) 0.86
In silico approaches for predicting ADME properties of drugs. Drug Metab Pharmacokinet (2004) 0.86
Efficient gene transfer into macrophages and dendritic cells by in vivo gene delivery with mannosylated lipoplex via the intraperitoneal route. J Pharmacol Exp Ther (2006) 0.86
Determination of matrine in rat plasma by high-performance liquid chromatography and its application to pharmacokinetic studies. Talanta (2003) 0.86
Uptake characteristics of galactosylated emulsion by HepG2 hepatoma cells. Int J Pharm (2005) 0.86
Hepatic uptake of negatively charged particles in rats: possible involvement of serum proteins in recognition by scavenger receptor. J Control Release (2004) 0.86
Photothermic regulation of gene expression triggered by laser-induced carbon nanohorns. Proc Natl Acad Sci U S A (2012) 0.85
Prediction of Caco-2 cell permeability using a combination of MO-calculation and neural network. Int J Pharm (2002) 0.85
Photodynamic and photothermal effects of semiconducting and metallic-enriched single-walled carbon nanotubes. J Am Chem Soc (2012) 0.85
Tryptophan pyrrole ring cleavage enzymes in placenta. Adv Exp Med Biol (2003) 0.85
Intranasal administration of CpG DNA lipoplex prevents pulmonary metastasis in mice. Cancer Lett (2009) 0.85
Inhibition of metastatic tumor growth in mouse lung by repeated administration of polyethylene glycol-conjugated catalase: quantitative analysis with firefly luciferase-expressing melanoma cells. Clin Cancer Res (2004) 0.85
Development of an antigen-presenting cell-targeted DNA vaccine against melanoma by mannosylated liposomes. Biomaterials (2007) 0.85
In vitro evaluation of inhibitory effect of nuclear factor-kappaB activity by small interfering RNA on pro-tumor characteristics of M2-like macrophages. Biol Pharm Bull (2013) 0.84